Korean scientists claim new alcoholic fatty liver drug possible

Published: 2009-04-08 06:57:00

Updated: 2009-04-08 06:57:00

Korean scientists claim to have developed a natural drug derived from magnolia extracts (SPA002 and SPA005) that they say could bring innovations in the treatment of alcohol-induced liver disease.

In a study published by peer-review journal, Toxicology & Applied Pharmacology, a research team l...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK